Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: GLP-1 RA for Stage 1 Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a GLP-1 receptor agonist for Stage 1 Type 1 diabetes is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 receptor agonist

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Stage 1 Diabetes Mellitus, Type 1 | Phase 2 | Status: NOT_YET_RECRUITING